MARKET

SNCE

Science 37 Holdings Inc
SNCE
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-42.7960
0.5683
0.6618
34,661,960.25
Science 37 Holdings Inc: Statement of changes in beneficial ownership of securities
Press release · 03/12 16:02
Science 37 Holdings Inc: Current report
Press release · 03/12 14:02
Craig-Hallum Releases a Hold Rating on Science 37 (SNCE)
TipRanks · 03/12 12:56
Science 37 Merges with eMed, Restructures, and Delists from Nasdaq
TipRanks · 03/12 12:42
Press Release: eMed completes tender offer for all outstanding shares of Science 37
EMed completes tender offer for all outstanding shares of Science 37 Holdings, Inc. At a price of USD 5.75 per share. 4,715,950 shares were validly tendered and not withdrawn in the tender offer. Science 37 will be a wholly-owned subsidiary of eMed.
Dow Jones · 03/12 10:45
Weekly Report: what happened at SNCE last week (0304-0308)?
Weekly Report · 03/11 09:39
Weekly Report: what happened at SNCE last week (0226-0301)?
Weekly Report · 03/04 09:40
Science 37 Holdings Inc <SNCE.OQ> expected to post a loss of $1.23 a share - Earnings Preview
Science 37 Holdings Inc expected to post a loss of $1.23 a share. The company is expected to report a fall in quarterly revenue to $14.048 million from $15.94 million a year ago. The average analyst estimate is for Science 37 Holdings to show a fall of 11.8% in revenue.
Reuters · 03/01 14:05
More

Webull offers Science 37 Holdings Inc stock information, including NASDAQ: SNCE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNCE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNCE stock methods without spending real money on the virtual paper trading platform.